The company focuses on the production of protein-based (biological) molecules with unique physical and biochemical properties. With its recombinant antigens, bisy BIOS GmbH develops novel strategies for antibody testing and the basis for vaccine tests. In the future, another focus will be the production and research of alternatives to antibiotics.
Research field / product range:
biopolymers, yeast strains, development of novel
strategies for antibody testing
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.